Meta‐Analysis of Placebo‐Treated Patients: Dropout Rates From Treatment in MASH Randomised Controlled Trials

Documenti analoghi

• Clinical Trial: Semaglutide Versus Placebo in NIT ‐Assessed MASH —A Multicenter Randomised Placebo‐Controlled Trial ( SAMARA )
  di: Veeral Ajmera, et al.
  Pubblicazione: (2026)
• Research Communication: Teriflunomide Does Not Affect Gluten‐Specific T‐Cell Activity in Coeliac Disease—A Randomised, Placebo‐Controlled Trial
  di: Louise F. Risnes, et al.
  Pubblicazione: (2025)
• Network Meta‐Analysis: Comparison of Pharmacological Therapies in Compensated Metabolic Dysfunction‐Associated Steatohepatitis Cirrhosis for Fibrosis Regression and MASH Resolution
  di: Matheus Souza, et al.
  Pubblicazione: (2026)
• Lubiprostone Reduces Fat Content on MRI‐PDFF in Patients With MASLD: A 48‐Week Randomised Controlled Trial
  di: Mohamed El‐Kassas, et al.
  Pubblicazione: (2025)
• Clinical Trial: Safety and Efficacy of a Novel Oesophageal Delivery System for Topical Corticosteroids Versus Placebo in the Treatment of Eosinophilic Oesophagitis
  di: Alfredo J. Lucendo, et al.
  Pubblicazione: (2024)